06887 SUNSHINE PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.03X | Oper Margin | 9.5% |
|---|---|---|---|
| LT Debt/Equity | 693.5% | Net Margin | N/A |
| Total Debt/Equity | 1,343.7% | Return on Equity | N/A |
| Price/Book | N/A | Return on Assets | N/A |
| (HKD 55.450) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -220.61 | 203.82 | -1,355.76 |
|---|---|---|---|
| Net Profit Growth (%) | -208.2 | +115.0 | N/A |
| Earnings Per Share (HKD) | -0.5 | 0.486 | -4.112 |
| Earnings Per Share Growth (%) | -202.9 | +111.8 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | 114.05 | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | |
| Cover Period (mths) | 6 | 6 | NA | |
|---|---|---|---|---|
| Turnover | 1,938 | 2,582 | -24.9 | |
| Operating Result | 103.148 | 607.736 | -83.0 | |
| Associates | 0.049 | -0.016 | -406.3 | |
| Profit Before Taxation | 95.653 | 607.72 | -84.3 | |
| Taxation | 81.001 | 134.293 | -39.7 | |
| Profit /( Loss) After Taxation | 14.652 | 473.427 | -96.9 | |
| Minority Interests | 61.022 | 331.284 | -81.6 | |
| Net Profit | -46.37 | 142.143 | -132.6 | |
| Earnings Per Share () | -0.1152 | 0.3464 | -133.3 | |
| Announcement Date | 2025-08-29 | 2025-08-29 | NA |
* Annualised
Last Update Time: 2025-09-08 21:40:25
